InvestLog
ALLO Allogene Therapeutics, Inc. logo

ALLO Allogene Therapeutics, Inc.

Healthcare
$2.09+0.00%OpenMarket Cap: $509.7M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

1

Buy/Sell Ratio

0.00

Net Shares

-9,586

Shares Acquired

0

Shares Disposed

9,586

Total Bought ($)

$0.00

Total Sold ($)

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 23Yoshiyama Annieofficer: SVP, FinanceSell9,586$2.31124,517
Thu Apr 02Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell2,867$2.50195,338
Wed Mar 18Chang David Ddirector, officer: President and CEOSell47,763$2.475,150,599
Wed Mar 18Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell4,835$2.47198,205
Wed Mar 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,132$2.60203,040
Wed Feb 04Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERSell24,001$1.761,252,795
Wed Feb 04Chang David Ddirector, officer: President and CEOSell95,269$1.805,185,862
Wed Feb 04Chang David Ddirector, officer: President and CEOSell1,387,931$1.871,387,931
Wed Feb 04Chang David Ddirector, officer: President and CEOSell392,586$0.00392,586
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,549$1.73210,172
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell373,757$1.87373,757
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell105,720$0.00105,720